Market Overview:
The global cardiac marker analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising awareness about early diagnosis and treatment of heart diseases, and technological advancements in cardiac marker analyzers. Based on type, the global cardiac marker analyzer market is segmented into benchtop and portable devices. The benchtop devices segment is expected to account for a larger share of the global market than the portable devices segment during the forecast period. This can be attributed to their higher accuracy and reliability as compared to portable devices. Based on application, the global cardiac marker analyzer market is divided into hospitals, surgical centers, and others (including research institutes and diagnostic laboratories). The hospitals segment is expected to account for a larger share of this market than other segments during the forecast period owing to increasing demand for early diagnosis and treatment of heart diseases among patients admitted in hospitals.
Product Definition:
A cardiac marker analyzer is a device that is used to measure the levels of specific proteins in the blood that are associated with heart disease. These markers can be used to help diagnose heart problems, monitor the progress of treatment, and predict the risk of future heart events.
Bentchtop:
Bentchtop is a new technology that has been used in the field of oncology for more than 10 years. It helps to identify cancer cells by their gene expression. The technique works by detecting and measuring changes in cell signaling, which are associated with different genes. Bentchtop is based on the principle of protein-protein interaction, which takes place between an antibody or antigen-specific cell and a protein present on the surface of another cell.
Portable:
The portable and it's usage in cardiac marker analyzer market is expected to witness significant growth over the forecast period. The major drivers for this market are increasing prevalence of cardiovascular diseases, growing demand for point-of-care testing, and rising geriatric population base. Moreover, technological advancements such as development of microfluidics technology which helps in analysis at the molecular level are also one of the factors driving growth during upcoming years.
Application Insights:
The hospital segment dominated the global market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to a rise in cardiovascular diseases, which are the leading cause of death globally. According to WHO, around 1 out of 3 deaths occur due to CVDs. Thus, rising prevalence coupled with high treatment rates is driving demand for cardiac marker analyzers at hospitals across the world.
However, surgical centers are anticipated to exhibit fastest growth during forecast years as these centers require such equipment for accurate diagnosis of patients with chest pain or ECG abnormalities suggestive of acute coronary syndrome (ACS). Surgical center based cardiac marker analyzer tests have been found more sensitive than those conducted in laboratories; however they cost more and require skilled technicians for its use resulting in higher adoption at a premium price compared with that conducted at hospitals or other healthcare facilities.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies and increasing demand for minimally invasive surgeries. The region is expected to maintain its dominance over the forecast period due to continuous innovations in technology and growing awareness among people about cardiac diseases.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising medical tourism, improving healthcare facilities and rising disposable income especially in developing countries such as India, China & Japan. Moreover, a large number of patients suffering from heart failure are migrating from developed countries such as U.S., Germany & Canada which further boosts growth opportunities for manufacturers operating within Asia Pacific region.
The key players operating within North America include Abbott; Alta Devices Inc.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising awareness about CVDs and their risk factors
- Technological advancements in cardiac marker analyzers
- Increasing demand for point-of-care diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Marker Analyzer Market Research Report
By Type
Bentchtop, Portable
By Application
Hospital, Surgical Centers, Others
By Companies
Mitsubishi Chemical Medience, Cardio Genics, Trinity Biotech, Lifesign, Abbott Laboratories, Boditech, Beckman Coulter, Roche, Siemens Healthcare, Medtronic, Mitsubishi Chemical Medience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Marker Analyzer Market Report Segments:
The global Cardiac Marker Analyzer market is segmented on the basis of:
Types
Bentchtop, Portable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mitsubishi Chemical Medience
- Cardio Genics
- Trinity Biotech
- Lifesign
- Abbott Laboratories
- Boditech
- Beckman Coulter
- Roche
- Siemens Healthcare
- Medtronic
- Mitsubishi Chemical Medience
Highlights of The Cardiac Marker Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bentchtop
- Portable
- By Application:
- Hospital
- Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Marker Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cardiac marker analyzer is a medical device that measures the levels of specific cardiac markers in a patient's blood. These markers can help doctors diagnose and monitor heart disease, and may also be used to determine whether or not treatment is necessary.
Some of the major companies in the cardiac marker analyzer market are Mitsubishi Chemical Medience, Cardio Genics, Trinity Biotech, Lifesign, Abbott Laboratories, Boditech, Beckman Coulter, Roche, Siemens Healthcare, Medtronic, Mitsubishi Chemical Medience.
The cardiac marker analyzer market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Marker Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Marker Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Marker Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Marker Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Marker Analyzer Market Size & Forecast, 2020-2028
4.5.1 Cardiac Marker Analyzer Market Size and Y-o-Y Growth
4.5.2 Cardiac Marker Analyzer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bentchtop
5.2.2 Portable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Marker Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Marker Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bentchtop
9.6.2 Portable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bentchtop
10.6.2 Portable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bentchtop
11.6.2 Portable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bentchtop
12.6.2 Portable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bentchtop
13.6.2 Portable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Marker Analyzer Market: Competitive Dashboard
14.2 Global Cardiac Marker Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mitsubishi Chemical Medience
14.3.2 Cardio Genics
14.3.3 Trinity Biotech
14.3.4 Lifesign
14.3.5 Abbott Laboratories
14.3.6 Boditech
14.3.7 Beckman Coulter
14.3.8 Roche
14.3.9 Siemens Healthcare
14.3.10 Medtronic
14.3.11 Mitsubishi Chemical Medience
